Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13101751
Abstract: Nephropathy is a major Fabry disease complication. Kidney biopsies reveal glomerulosclerosis even in pediatric patients. The main manifestations of Fabry nephropathy include reduced glomerular filtration rate and proteinuria. In 2016, an oral pharmacological Chaperone was… read more here.
Keywords: biomarkers monitoring; monitoring renal; damage; review ... See more keywords